Cytodyn Inc (CYDY)

[The Lawman]

CYDY is clearly looking to sell or outlicense.

At yesterday's SSS conference, Pourhassan strongly implied the company is actively seeking a suitor to either buy the company or out license PRO 140.

When specifically asked about that subject, Pourhassan stated he was unable to say anything due to what he termed "confidentiality."

Although it might be premature to find a suitor or licensee, that appears to be the company's near term goal at this point.

Bringing Pestell on board might be a drawing card to potential suitors, along with excellent results in two late stage HIV trials, and the potential for other indications including GVHD, MS, and cancer.

The recent 50% run-up in the SP could be a sign that others suspect a buyout or licensing agreement is possible in the near future.

LM